Overview

INK Cells As Maintenance Therapy After Chemoradiotherapy for Small Cell Lung Cancer

Status:
ENROLLING_BY_INVITATION
Trial end date:
2026-12-14
Target enrollment:
Participant gender:
Summary
This is a clinical study on the use of iNK cells for the treatment of small cell lung cancer.
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
Guangzhou Ruixin Biotechnological Co., LTD
Collaborator:
Weifang People's Hospital